ACN (ACN) Price Target
Track Wall Street analyst price targets and coverage changes.
Consensus Price Target
$390.00
▲
21.8%
Upside
based on current price $320.18
High Target
$430.00
Median Target
$390.00
Low Target
$355.00
Analyst Coverage
Last Month
0
$0.00
Last Quarter
2
$372.50
Last Year
28
$362.57
Individual Price Targets
Latest Analyst Coverage
Date | Analyst | Firm | Target | Price When Posted | Upside | News |
---|---|---|---|---|---|---|
Mar 21, 2025 | BMO Capital | $355.00 | $305.32 | 16.3% | Accenture price target lowered to $355 from $370 at BMO Capital | |
Mar 17, 2025 | Robert W. Baird | $390.00 | $325.71 | 19.7% | Accenture upgraded to Outperform from Neutral at Baird | |
Dec 20, 2024 | Surinder Thind | Jefferies | $385.00 | $366.37 | 5.1% | Accenture price target raised to $385 from $355 at Jefferies |
Dec 19, 2024 | James Schneider | Goldman Sachs | $430.00 | $372.16 | 15.5% | Accenture price target raised to $430 from $420 at Goldman Sachs |
Dec 19, 2024 | David Grossman | Stifel Nicolaus | $390.00 | $372.16 | 4.8% | Accenture plc (ACN) PT Raised to $390 at Stifel |
Nov 05, 2024 | David Koning | Robert W. Baird | $370.00 | $346.28 | 6.8% | Baird Reiterates Neutral Rating on Accenture plc (ACN) |
Oct 30, 2024 | Stefan Slowinski | BNP Paribas | $375.00 | $354.17 | 5.9% | Accenture downgraded to Neutral from Outperform at Exane BNP Paribas |
Sep 30, 2024 | Bryan Bergin | TD Securities | $400.00 | $349.70 | 14.4% | Accenture upgraded to Buy from Hold at TD Securities |
Sep 27, 2024 | James Friedman | Susquehanna | $360.00 | $355.81 | 1.2% | Accenture price target raised to $360 from $350 at Susquehanna |
Sep 27, 2024 | Jonathan Lee | Guggenheim | $395.00 | $355.81 | 11.0% | Accenture price target raised to $395 from $380 at Guggenheim |
Sep 27, 2024 | James Faucette | Morgan Stanley | $335.00 | $355.81 | 0.0% | Accenture price target raised to $335 from $300 at Morgan Stanley |
Sep 26, 2024 | David Grossman | Stifel Nicolaus | $375.00 | $354.63 | 5.7% | Accenture price target raised to $375 from $340 at Stifel |
Sep 26, 2024 | Arvind Ramnani | Piper Sandler | $395.00 | $354.63 | 11.4% | Accenture upgraded to Overweight at Piper on 'attractive' FY25 set-up |
Sep 25, 2024 | Keith Bachman | BMO Capital | $380.00 | $336.96 | 12.8% | BMO Capital Reiterates Market Perform Rating on Accenture plc (ACN) |
Sep 20, 2024 | Arvind Ramnani | Piper Sandler | $329.00 | $333.14 | 0.0% | Accenture plc (ACN) PT Raised to $329 at Piper Sandler |
Sep 18, 2024 | Dan Dolev | Mizuho Securities | $365.00 | $337.04 | 8.3% | Accenture plc (ACN) PT Raised to $365 at Mizuho |
Sep 18, 2024 | David Koning | Robert W. Baird | $350.00 | $337.04 | 3.8% | Baird Reiterates Neutral Rating on Accenture plc (ACN) |
Sep 17, 2024 | Jason Kupferberg | Bank of America Securities | $365.00 | $337.04 | 8.3% | BofA Securities on Accenture plc (ACN): 'We view valuation as attractive' |
Sep 17, 2024 | Ashwin Shirvaikar | Citigroup | $405.00 | $338.23 | 19.7% | Accenture plc (ACN) PT Raised to $405 at Citi |
Jul 18, 2024 | Kevin McVeigh | UBS | $400.00 | $328.10 | 21.9% | Accenture upgraded to Buy from Neutral at UBS |
Jun 26, 2024 | James Faucette | Morgan Stanley | $300.00 | $307.17 | 0.0% | Accenture downgraded to Equal Weight from Overweight at Morgan Stanley |
Jun 21, 2024 | James Friedman | Susquehanna | $293.00 | $308.98 | 0.0% | These Analysts Slash Their Forecasts On Accenture After Q3 Results |
Jun 21, 2024 | Keith Bachman | BMO Capital | $350.00 | $308.98 | 13.3% | These Analysts Slash Their Forecasts On Accenture After Q3 Results |
Jun 20, 2024 | David Togut | Evercore ISI | $375.00 | $304.78 | 23.0% | Accenture plc (ACN) PT Lowered to $375 at Evercore ISI |
Jun 18, 2024 | Dan Dolev | Mizuho Securities | $350.00 | $285.53 | 22.6% | Accenture price target lowered to $350 from $398 at Mizuho |
Jun 17, 2024 | Arvind Ramnani | Piper Sandler | $320.00 | $284.27 | 12.6% | Accenture plc (ACN) PT Lowered to $320 at Piper Sandler |
Jun 12, 2024 | David Grossman | Stifel Nicolaus | $340.00 | $294.22 | 15.6% | Accenture plc (ACN) PT Lowered to $340 at Stifel |
Jun 05, 2024 | Surinder Thind | Jefferies | $275.00 | $288.06 | 0.0% | Accenture price target lowered to $275 from $340 at Jefferies |
Related Metrics
Explore detailed financial metrics and analysis for ACN.